Results 181 to 190 of about 1,249,651 (293)

Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2803-2813, August 2025.
Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem   +13 more
wiley   +1 more source

Neurological Disease Syndrome Caused by a STAG1 Gene Variant: A Case Report and Literature Review

open access: yesInternational Journal of Developmental Neuroscience, Volume 85, Issue 5, August 2025.
We present a case of a child with a neurodevelopmental disorder associated with a mutation in the STAG1 gene, aiming to raise awareness of this type of disorder. ABSTRACT Background The cohesin complex is a multifunctional unit that plays a crucial role in DNA repair, replication, chromosome segregation, and gene expression.
Qi Zhang   +5 more
wiley   +1 more source

EFFECTS OF A KETOGENIC DIET ON POSTABSORPTIVE AND POSTPRANDIAL HORMONE RESPONSES TO A FAT-RICH MEAL

open access: bronze, 2001
J. S. Volek   +5 more
openalex   +1 more source

Anesthetic Management of a Pediatric Patient on the Ketogenic Diet: A case report [PDF]

open access: bronze, 2005
Hyun Jeong Kwak   +3 more
openalex   +1 more source

Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

open access: yesObesity, Volume 33, Issue 8, Page 1475-1503, August 2025.
Abstract Background Glucagon‐like peptide 1 receptor agonists and combination medications (hereafter collectively referred to as GLP‐1s) are shifting the treatment landscape for obesity. However, real‐world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP‐1 efficacy, equitable results, and ...
Dariush Mozaffarian   +17 more
wiley   +1 more source

FASTING AND POSTPRANDIAL LIPOPROTEIN RESPONSES TO A KETOGENIC DIET

open access: bronze, 2001
Matthew J. Sharman   +6 more
openalex   +1 more source

Safety and effectiveness of stiripentol in patients with Dravet syndrome: A prospective, 3‐year, postmarketing surveillance study

open access: yesDevelopmental Medicine &Child Neurology, Volume 67, Issue 8, Page 1034-1041, August 2025.
Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16285 Abstract Aim To conduct a postmarketing surveillance study of patients with Dravet syndrome in Japan to investigate the safety and effectiveness of long‐term, real‐world, clinical use of stiripentol (STP).
Yuki Kitamura   +6 more
wiley   +1 more source

A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis [PDF]

open access: gold, 2006
Zhong Zhao   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy